Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
01/2006
01/05/2006US20060003958 Novel polynucleotides related to oligonucleotide arrays to monitor gene expression
01/05/2006US20060003957 RNA virus expression and replication, methods and uses therefor
01/05/2006US20060003956 Materials and methods for the derepression of the E-cadherin promoter
01/05/2006US20060003955 Immunostimulatory nucleic acid molecules
01/05/2006US20060003954 Inhibiting the expression of a wild type COL1A1 gene to treat a lung disease relating to a collagen disorder
01/05/2006US20060003953 Compositions and their uses directed to bone growth modulators
01/05/2006US20060003952 Oligomeric compounds having modified phosphate groups
01/05/2006US20060003937 Urocortin-III and uses thereof
01/05/2006US20060003936 Method for modulating the production of a selected protein in vivo
01/05/2006US20060003934 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction
01/05/2006US20060003929 variants or fragments of the Drosophilia sog proteins, used in the therapy of alopecia, cancers or neurodegenerative disorders
01/05/2006US20060003915 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
01/05/2006US20060003434 Protein of given sequence; identifying compound that modulates cellular response to DNA damage by measuring activitiy in mixture of enzyme, magnesium ion and substrate
01/05/2006US20060003433 Catalyzing hydrolysis of xylans in beverage, feed, food or polysaccharide to produce a smaller molecular weight xylose and xylo-oligomer; have increased activity and stability at increased pH and temperature; catalyzing hydrolysis of internal beta -1,4-xylosidic or endo- beta -1,4-glucanase linkages
01/05/2006US20060003430 Lysophosphatidic acit acetyltransferases
01/05/2006US20060003420 Monomeric and dimeric fluorescent protein variants and methods for making same
01/05/2006US20060003419 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
01/05/2006US20060003414 Signal peptide for producing a polypeptide
01/05/2006US20060003413 Novel human protein kinase, phosphatase, and protease family members and uses thereof
01/05/2006US20060003412 Protein engineering with analogous contact environments
01/05/2006US20060003411 Mutated D-aminotransferase and method for producing optically active glutamic acid derivatives using the same
01/05/2006US20060003410 Oxidoreductase for use in identifying modulators for prevention and treatment of diabetes, obesity, dyslipidemia, coronary heart, inflammatory and cancer disorders
01/05/2006US20060003409 Novel molecules of the card-related protein family and uses thereof
01/05/2006US20060003408 Acid-stable alpha amylases having granular starch hydrolyzing activity and enzyme compositions
01/05/2006US20060003407 Methods for preparing highly active april ligand polypeptides
01/05/2006US20060003403 Carotenoid ketolase genes with improved ketocarotenoid yield
01/05/2006US20060003393 Pathogenicity determinants which can be used as targets for developing means for preventing and controlling bacterial infections and/or systemic dissemination
01/05/2006US20060003387 Cell display libraries
01/05/2006US20060003380 Human tumor necrosis factor receptor TR-17
01/05/2006US20060003379 Smad6 and uses thereof
01/05/2006US20060003378 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics
01/05/2006US20060003377 Therapeutic and diagnostic proteins comprising a SOCS box
01/05/2006US20060003375 Novel polypeptide - human retinoic acid-responsive protein 53.57 and a polynucleotide encoding the same
01/05/2006US20060003369 Provision of DNA investigating tools
01/05/2006US20060003367 Polynucleotides encoding a novel human Kupffer cell receptor protein, BGS-18
01/05/2006US20060003358 Polymorphic kinase anchor proteins and nucleic acids encoding the same
01/05/2006US20060003355 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/05/2006US20060003349 Tm leveling compositions
01/05/2006US20060003348 Omi PDZ modulators
01/05/2006US20060003342 Fetal RNA in amniotic fluid to determine gene expression in the developing fetus
01/05/2006US20060003341 Cloned genes encoding reverse transcriptase lacking RNase H activity
01/05/2006US20060003333 Preparation of defined highly labeled probes
01/05/2006US20060003332 Method for multiplex PNA-FISH
01/05/2006US20060003331 Immobilised metal ion adsorption chromatography resin to adsorb and desorb thioated nucleotides; reduces need of organic solvents and/or high pressures
01/05/2006US20060003330 Streptococcus pneumoniae pbp2x mini-protein and uses thereof
01/05/2006US20060003326 Bioconjugation; spiegelmers, aptamers
01/05/2006US20060003316 Immunogenic compositions derived from poxviruses and methods of using same
01/05/2006US20060003315 Membrane-anchored beta2 microglobulin covalently linked to mhc class 1 peptide epitopes
01/05/2006US20060002993 Genetic engineered protein; transgenic animal, used to elicit a humoral or cellular immune response
01/05/2006US20060002952 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
01/05/2006US20060002950 Immunomodulatory protein derived from Trypanosomes and uses thereof
01/05/2006US20060002948 Polypeptide isolated from Dermatophagoides; use of polypeptides, polynucleotides and/or antibodies in therapy and diagnosis of allergic disorders; genetic engineering
01/05/2006US20060002947 Ii-key/antigenic epitope hybrid peptide vaccines
01/05/2006US20060002946 Targeted immunogens
01/05/2006US20060002945 Non-sensitive antigenic peptide derived from fc portion of the epsilon heavy chain of immunoglobulin-E for use in treatment and prevention of allergic disorders
01/05/2006US20060002931 Antibodies of angiogenesis inhibiting domains CD148
01/05/2006US20060002926 isolated and/or recombinant; characterized by high affinity binding of one or more chemokines, such as eotaxin, RANTES and/or MCP-3, and/or the ability to stimulate a (one or more) cellular response(s) (e.g., chemotaxis, exocytosis, release of one or more inflammatory mediators)
01/05/2006US20060002923 Recombinant anti-osteopontin antibody and use thereof
01/05/2006US20060002919 15625 receptor, a novel G-protein coupled receptor
01/05/2006US20060002904 Receptor and related products and methods
01/05/2006DE102004028778A1 An oligopeptide, useful for controlling the biological activity of cellular biomolecules, comprising at least one cysteine residue and two alpha helical zones
01/05/2006CA2560631A1 Improved inhibitor nucleic acids
01/05/2006CA2549830A1 Selective incorporation of 5-hyroxytryptophan into proteins in mammalian cells
01/04/2006EP1611249A1 Oligoribonucleotides and ribonucleases for cleaving rna
01/04/2006EP1610802A2 Parkin interacting polypeptides and methods of use
01/04/2006EP1552001A4 Methods and compositions for detecting targets
01/04/2006EP1534744A4 Altered insulin-like growth factor binding proteins
01/04/2006EP1319047B1 Cyanine dyes
01/04/2006EP1223950B1 Ribozyme therapy for the treatment of proliferative eye diseases
01/04/2006EP1183390B1 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
01/04/2006EP0868535B2 Methods and compositions for determining the sequence of nucleic acid molecules
01/04/2006EP0668931B1 Nucleic acid ligands and methods for producing the same
01/04/2006CN1717482A Device for pretreating specimen
01/04/2006CN1717413A Novel PTH responsive gene
01/04/2006CN1717412A Method and apparatus for concentration and purification of nucleic acid
01/04/2006CN1715918A Configurable dynamic three dimensional array
01/04/2006CN1234866C Nucleotide peculiar to 0-antigen of 17 type Baoshi Sh. dysenterae
01/04/2006CN1234865C Nucleotide peculiar to 0-antigen of 16 type Baoshi Sh.dysenterae
01/04/2006CN1234864C Nucleotide peculiar to 0-antigen of 164 type bacillus oil
01/04/2006CN1234863C Nucleotide peculiar to 0-antigen of 0130 type bacillus coli
01/04/2006CN1234862C Nucleotide peculiar to 0-antigen of 0100 type bacillus coli
01/04/2006CN1234861C Nucleotide peculiar to 0-antigen of 095 type bacillus coli
01/04/2006CN1234860C Nucleotide peculiar to 0-antigen of 088 type bacillus coli
01/04/2006CN1234859C Nucleotide peculiar to 0-antigen of 061 type bacillus coli
01/04/2006CN1234858C Nucleotide peculiar to 0-antigen of -56 type bacillus coli
01/04/2006CN1234857C Nucleotide peculiar to 0-antigen of 051 type bacillus coli
01/04/2006CN1234856C Nucleotide peculiar to 0-antigen of 049 type bacillus coli
01/04/2006CN1234855C Recombinant Flt3 ligand gene and its fusion gene and product
01/04/2006CN1234728C Novel human lymphokine, its coding sequence and use
01/04/2006CN1234720C Detection systems for registering protein interactions and functional relationships
01/04/2006CN1234719C Nucleotide with specificity to o-antigen of type-12 shigel shigae and colibacillus 0152
01/03/2006US6982363 UDP-glucose modifiers
01/03/2006US6982326 Allergenic proteins and peptides from Japanese cedar pollen
01/03/2006US6982325 Gene encoding protein having aurone synthesizing activity
01/03/2006US6982162 Genetically engineered microorgaism for use as diagnostic tool
01/03/2006US6982159 Trichoderma β-glucosidase
01/03/2006US6982156 comprises antibodies against Smallpox Inhibitor of Complement Enzyme (SPICE) or Vaccinia Virus Complement Control Protein (VCP); dna vaccines
01/03/2006US6982153 DNA sequences from staphylococcus aureus bacteriophage 77 that encode anti-microbial polypeptides
01/03/2006US6982149 Fiber array and methods for using and making same
01/03/2006US6982147 Apparatus for use in detecting preferential binding of probes to targets